NASDAQ: GOVXGeovax Labs Inc Stock Ownership - Who owns Geovax Labs?
Insider buying vs selling
Have Geovax Labs Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| John N. Spencer Jr. | Director | 2025-10-17 | 10,000 | $0.55 | $5.50kBuy |
| Kelly T. McKee Jr. | Chief Medical Officer | 2025-08-07 | 1,107 | $0.67 | $741.69Buy |
| John W. Sharkey | VP Business Development | 2025-04-10 | 6,000 | $0.99 | $5.94kBuy |
| John N. Spencer Jr. | Director | 2025-04-10 | 10,000 | $0.98 | $9.80kBuy |
| David A. Dodd | President CEO | 2025-04-01 | 10,000 | $1.08 | $10.80kBuy |
| Mark Reynolds | CFO | 2025-03-31 | 6,800 | $1.08 | $7.34kBuy |
GOVX insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when GOVX insiders and whales buy or sell their stock.
GOVX Shareholders
What type of owners hold Geovax Labs Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| University Emory | 911.17% | 231,070,253 | $133.79M | Insider |
| Andrew J. Kandalepas | 84.03% | 21,310,065 | $12.34M | Insider |
| Robert T. McNally | 5.18% | 1,314,119 | $760.87k | Insider |
| Harriet L. Robinson | 4.63% | 1,173,726 | $679.59k | Insider |
| Donald G. Hildebrand | 4.22% | 1,071,400 | $620.34k | Insider |
| Peter M. Tsolinas | 1.70% | 431,734 | $249.97k | Insider |
| Ubs Group Ag | 0.79% | 200,257 | $115.95k | Institution |
| Vanguard Group Inc | 0.45% | 115,156 | $66.68k | Institution |
| Geode Capital Management LLC | 0.42% | 106,955 | $61.93k | Institution |
| Morgan Stanley | 0.20% | 50,120 | $29.02k | Institution |
GOVX vs Biotech Stocks
Geovax Labs Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.